
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

39237597
71435
10.1038/s41598-024-71435-x
Article
Collagen protein-chitosan nerve conduits with neuroepithelial stem cells promote peripheral nerve regeneration
Yun Chenping 1
Li Wei 2
Qiao Yongjie 3
Xiao Hecun 4
Qu Baoming 5
Xu Tao 307040527@qq.com

6
Li Tao litao9654@sdfmu.edu.cn

17
1 https://ror.org/05jb9pq57 grid.410587.f Department of Neurosurgery, The Third Affiliated Hospital of Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117 Shandong China
2 grid.410638.8 0000 0000 8910 6733 Department of Anesthesia, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021 Shandong China
3 Department of Pharmacy, The People’s Hospital of Jimo, Qingdao, 266299 Shandong China
4 https://ror.org/01fd86n56 grid.452704.0 0000 0004 7475 0672 Department of Nephrology, Second Hospital of Shandong University, Jinan, 250033 Shandong China
5 Department of Basic Medicine, Qilu Institute of Technology, Jinan, 250200 China
6 grid.410645.2 0000 0001 0455 0905 Department of Traditional Chinese Medicine, Qingdao Women and Children’s Hospital, Qingdao University, Qingdao, 266013 Shandong China
7 https://ror.org/05jb9pq57 grid.410587.f Department of Neurosurgery, The Third Affiliated Hospital of Shandong First Medical University, Shandong First Medical University, Jinan, 250031 Shandong China
5 9 2024
5 9 2024
2024
14 207483 12 2023
28 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
The peripheral nervous system consists of ganglia, nerve trunks, plexuses, and nerve endings, that transmit afferent and efferent information. Regeneration after a peripheral nerve damage is sluggish and imperfect. Peripheral nerve injury frequently causes partial or complete loss of motor and sensory function, physical impairment, and neuropathic pain, all of which have a negative impact on patients’ quality of life. Because the mechanism of peripheral nerve injury and healing is still unclear, the therapeutic efficacy is limited. As peripheral nerve injury research has processed, an increasing number of studies have revealed that biological scaffolds work in tandem with progenitor cells to repair peripheral nerve injury. Here, we fabricated collagen chitosan nerve conduit bioscaffolds together with collagen and then filled neuroepithelial stem cells (NESCs). Scanning electron microscopy showed that the NESCs grew well on the scaffold surface. Compared to the control group, the NESCs group contained more cells with bigger diameters and myelinated structures around the axons. Our findings indicated that a combination of chitosan-collagen bioscaffold and neural stem cell transplantation can facilitate the functional restoration of peripheral nerve tissue, with promising future applications and research implications.

Keywords

Chitosan
Biological scaffolds
Peripheral nerve regeneration
Immune microenvironment
Subject terms

Biotechnology
Cell biology
Stem cells
Neurology
Shandong Provincial Medical and Health Science and Technology Development Plan202104040051 Xu Tao Youth Science Fund Cultivation Grant Program of Shandong First Medical University (Shandong Academy of Medical Sciences)No. 202201-106 Xu Tao issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

Peripheral nerve injury frequently results in limb dysfunction, which has a major negative impact on patients’ quality of life and presents a significant difficuly for both patients and doctors. Although nerve stump anastomosis and autologous nerve transplantation can be used to repair nerves, the long distance between nerve stumps significantly limits therapeutic options for peripheral nerve injures. Currently, one of the hottest research topics is trying to find novel ways to heal peripheral nerve. Extensive research evidence supports cell-based approaches to peripheral nerve healing1,2. The local microenvironment plays an important role in the regeneration of nerve fibers, and Schwann cells are the key to the inner process of nerve regeneration. However, broad axonal contact lose may cause it to become dysfunctional due to extracellular matrix-integrin interactions and oxidative stress. Therefore, in cell-based therapeutic approaches, various bioscaffolds have been effectively demonstrated to synergize with neural progenitor cells to achieve functional neural tissue formation3,4.

As a significant part of the extracellular matrix, collagen is crucial for the migration and regeneration of Schönwang5. Collagen is an ideal material for neural tissue engineering because of its low antigenicity and strong biocompatibility, which help to promote tissue regeneration. The drawbacks of collagen, such as its fast degradation rate and poor space maintenance abilities, limit its application as a bioscaffold alone. Crustaceans, including shrimp and crab, are rich in chitosan, a rare positively charged polymeric saccharide found in nature. Chitosancan has numerous potential applications in the event of peripheral nerve damage, including the promotion of axon regeneration and the prevent neuromas forming following injury6,7. However, the brittleness and poor toughness of pure chitosan scaffolds limit their application as carriers. In recent years, the use of collagen and chitosan composites in the treatment of diseases such as bone regeneration, spinal cord injury, and TBI has expanded8–10.

Stem cell transplantation is a promising treatment for neural repair. The collagen/chitosan scaffold is biocompatible and can stimulate nerve healing in collaboration with stem cell transplantation, including mesenchymal stem cells and periodontal membrane stem cells11,12. Studies have demonstrated that neuroepithelial stem cells may survive on chitosan fibers and convert into neurons and glial cells, both of which have high biocompatibility, making them useful in the treatment of peripheral nerve injury13,14. NESCs develop from the neural plate and neural tube in the early embryo. They are the most primordial neural stem cells, capable of self renewal and differentiation into neurons and glial cells. NESCs are useful seed cells in neural tissue engineering because of their great cell survival and low immunogenicity.

Through animal experiments, we have demonstrate that collagen-chitosan composite catheters are noticeably better than silicone catheters in promoting regeneration and functional repair of injured rat sciatic nerves15. However, it is still unclear whether NESCs attach to collagen-chitosan composite conduits in the repair of peripheral nerve injury. In this study, the collagen protein–chitosan nerve conduits were made in a 3:1 ratio by freeze-drying, and NESCs were subsequently filled with them. After the operation, the effect of the collagen protein-chitosan nerve conduits combined with NESCs on nerve regeneration were evaluated in a rat sciatic nerve transection model utilizaing immunohistochemistry, nerve retrograde tracing, and electron microscopy.

Materials and methods

Preparation of the collagen protein-chitosan scaffold

The collagen protein-chitosan scaffold was prepared in accordance with published methods. Following the removal of fascia and adipose tissue, the cattle tendons were frozen and cut into 1–2 mm slices. After sterilization and drying, the sections were placed in 0.1% trypsin, incubated for 16 h at 37 °C, and then dried at room temperature. The sections were immersed in 80 ml of saline and 0.2 ml of 3% hydrogen peroxide for 20 min, then washed with physiological saline and dried at room temperature. The samples were soaked in 200 ml of 0.5 mmol/l hydrochloric acid for 24 h. After pulverizing the mixture, the viscosity was adjusted with 100–150 ml of acetic acid at the same concentration to remove eliminate any undissolved matter. Homogenates were prepared and stored at 0–4 °C until needed.

Chitosan was provided by Shandong Univeristy’s Institute of Physical Chemistry, School of Pharmacy. Chitosan was dissolved in 3% acetic acid and stirred in 50 °C water to create a 3% solution. The collagen protein and chitosan were mixed at a mass ratio of 3:1. The mixture was centrifuged at 3000 r/min for 15 min, frozen at − 35 °C for 2 h and it was then put right into a freeze dryer that had been precooled. The scaffold made of chitosan and collagen protein was completed forty hours later.

Isolation, culture, and identification of NESCs

Pregnant 11-day-old Wistar rats were provided by the Laboratory Animal Center of Shandong University. NESCs were isolated and cultured in accordance with the literature 12. In brief, 11-day-old pregnant Wistar rat embryos were removed under sterile conditions, with the neural tube isolated under a dissecting microscope and placed in D-Hank’s solution. The separated neural tube tissue was placed in a centrifuge tube, digested with 0.25% trypsin at 37 °C for 10 min, centrifuged at 800 r/min for 5 min, and suspended in DMEM/F12 media containing 10 ng/ml bFGF and 1:50 B27. The cells were incubated at 37 °C in 5% CO2 at a density of 106/ml. The basic medium was refreshed every 3 days. After 3–5 days, NESCs hung and formed neurospheres, which were mechanically dissected for passage. Second-generation neurospheres were inoculated into 24-well plates, and Nestin staining was performed after 4 h. A fluorescence microscope was used to monitor and photograph the cells.

NESCs cultured on collagen protein-chitosan scaffolds

The collagen protein-chitosan film was sliced into 12 mm × 8 mm pieces and sterilized using γ-rays. After three washes with D-Hanks, the films were coated in 24-well plates. The second passage of NESCs was planted on the collagen-chitosan film at a density of 107/ml and incubated at 37 °C in an incubator with 5% CO2 and 95% relative humidity. The cells were examined using a scanning electron microscope (SEM) 48 h after plating.

Preparation of sciatic nerve defect models and NESC transplantation

All male Wistar rats weighing between 220 and 250 g were provided by the Laboratory Animal Center at Shandong University. Wistar rats were randomly assigned to one of two groups: NESCs-collagen-chitosan group (NESCs group) and collagen-chitosan group (control group). Each group had 16 animals.

Rats’ right sciatic nerves was exposed after being deeply anesthetized with sodium pentobarbital (40 mg/kg body weight, i.p.). The sciatic nerve segment 5 mm distal to the inferior border of the piriformis was removed, resulting in a 10 mm long lesion after nerve terminal retraction. The collagen-chitosan membrane was formed into a single-layer cylindrical collagen-chitosan composite porous scaffold measuring approximately 1 mm, 12 mm long and 1.2 mm in diameter. Nerve defects were bridged using NESCs-collagen or collagen-chitosan scaffolds. Both the proximal and distal stumps of the nerves were inserted into the scaffolds at 1.0 mm and sutured using three needles. All animals were kept in temperature and humidity-controlled rooms under standard laboratory conditions, with unlimited access to food and water.

Electrophysiological evaluation

Nerve conduction latency was assessed 14 weeks following surgery using an electromyography device (Dantec Keypoint, Denmark). The stimulating electrode was placed in the sciatic nerve’s superficial section, between the sciatic tubercle and the greater trochanter, while the recording electrode was positioned in the triceps calf. The nerve conduction latency, distance between electrodes, and amplitude of nerve action potentials were all recorded and calculated.

Retrograde neuronal tracing

To determine whether dorsal root ganglion (DRG) neurons and spinal neurons had regenerated through the nerve scaffold, a retrograde neuronal labeling technique was employed. The retrograde neuronal labeling technique using Lumafluor fluorescent tracer (Lumafluor, USA) was used to measure neural route reconstruction 14 weeks following transplantation, as described by the manufacturer. After exposing the sciatic nerve, 100 nl of Lumafluor fluorescent tracer was injected into the inside of the sciatic epineurum for 5–10 min at a distance of 3 mm from the regenerated nerve. After 48 h of recovery, the animals were reanesthetized and 4% paraformaldehyde was perfused through the ascending aorta. The spinal cord from the enlarged lumbar segment was removed, fixed with 4% paraformaldehyde for 12 h, and immmersed in 30% sucrose in 0.1 M PBS overnight. After freezing at − 20 °C, serial lateral 20 μm thick frozen slices were taken from the DRGs via a freezing microtome. The sections were collected and examined using a fluorescence microscope. The sciatic nerve was traced using the above method.

Transmission electron microscopy (TEM) and toluidine blue staining

At 14 weeks after surgery, toluidine blue staining and TEM were utilized to observe 5 mm of the proximal end of the regenerated nerve. The specimens were fixed by immersion in 2.5% glutaraldehyde for 24 h before being fixed in 1% osmium tetroxide at 4 °C for 2 h. They were then dehydrated in a graded ethanol series (50%, 70%, 90%, 100%) and acetone for 15 min at each concentration. They were then infiltrated with resin and polymerized for 48 h at 60 °C. Eight semithin slices were cut from each specimen and stained with toluidine blue for light microscopy analysis. Images of the toluidine blue-stained semithin nerve sections were digitized and analyzed using Image-Pro Plus 6.0 software. The specimens were cut into ultrathin sections and stained with uranyl acetate and lead citrate for 2 min before TEM.

Statistical analysis

All data are expressed as the mean ± standard deviation (SD). Statistical analyses were performed using the SPSS 26.0 software package. Significant differences between two groups were analyzed by t tests. Differences were considered statistically significant at p < 0.05.

Results

The amplification and identification of NESCs

After 2 days of culture in serum-free medium, the extracted NESCs formed suspension neurospheres composed of several or a dozen cells and grew into neurospheres composed of dozens or even hundreds of cells on the 5th day (Fig. 1A). Immunocytochemical staining revealed that the neurospheres were positive for Nestin (red), indicating that the amplified cells were NESCs (Fig. 1B).Fig. 1 The proliferation and identification of NESCs. (A) Suspended growth neurospheres formed when NESCs were cultured in vitro for 5 days. (B) Neurosphere Nestin immunofluorescence staining was positive, showing that the amplified cells were NESCs.

NESCs can survive on collagen-chitosan membranes

Two days after the NESCs were seeded on the collagen-chitosan scaffolds, the NESCs were observed to attach to the scaffold surface, with protrusions growing and connecting to a network (as shown in Fig. 2A–C). Figure 2D shows that we separated the sciatic nerve. Fourteen weeks after the operation, the collagen chitosan protein conduit had degraded, and the sciatic nerve was connected. (as shown in Fig. 2E,F).Fig. 2 NESCs grow on collagen-chitosan membranes. (A) SEM image (× 2500) of NESCs attached to a collagen-chitosan membrane with protrusions growing and connecting into a network. (B) Neurospheres extended to the surroundings. (C) NESCs grow with protrusions. (D) Mode diagram of surgical operation. (E) The right sciatic nerve was exposed, and the injury was approximately 10 mm long. (F) The injured sciatic nerve was repaired after 14 weeks.

Electrophysiological results of regenerated nerves

At 14 weeks after the operation, the nerve conduction latency and amplitude of the animals in each group were detected by electromyography, and the nerve conduction latency rate was calculated. The results showed that compound muscle action potentials were detected in both groups of animals, and the nerve conduction latency rate (23.84 ± 2.14 m/s) and amplitude (9.74 ± 1.18 mv) in the NESCs group were significantly greater than those in the control group (19.75 ± 1.12 m/s and 6.03 ± 0.67 m/v, respectively) (as shown in Table 1), and the differences were statistically significant (as shown in Fig. 3A,B). Table 1 Comparison of nerve conduction between the NESC group and the CTRL group.

Group	Nerve conduction latent rate (m/s)	Amplitude value (mv)	
Collagen-chitosan scaffolds group (control group)	19.75 ± 1.12	6.03 ± 0.67	
NESCs-collagen-chitosan scaffolds group (NESCs group)	23.84 ± 2.14*	9.74 ± 1.18**	

Fig. 3 Comparison of nerve conduction between the NESCs group and the CTRL group. (A) Comparison of the nerve conduction latency rates between the two groups. (B) Comparison of nerve conduction amplitude between the two groups. *p < 0.05, **p < 0.01 for the NESCs group vs the CTRL group.

Toluidine blue staining and TEM analysis

Toluidine blue staining and TEM were used to compare the structural changes in axons in the proximal regenerated sciatic nerve at 14 weeks after surgery between the two groups of animals. The results of toluidine blue staining showed that compared with those in the control group, the regenerated axons in the NESCs group had more obvious myelination, more myelinated fibers, and a larger diameter (as shown in Fig. 4A,B), and the difference was statistically significant. The TEM results showed that compared with those in the control group, the number of regenerated fibers in the NESCs group was greater, the diameter was greater (as shown in Table 2), and some Schwann cells could form the myelin sheath structure around the axon (as shown in Fig. 4C,D); these differences were statistically significant (as shown in Fig. 4E).Fig. 4 Toluidine blue staining of nerve fibers and TEM analysis of the two groups. (A) Toluidine blue staining of the CTRL group (× 100). (B) Toluidine blue staining of the NESCs group (× 100). (C) Nerve fibers of the CTRL group by TEM (× 7500). (D) Nerve fibers of the NESCs group by TEM (× 7500). (E) Comparison of regenerated nerve fiber density, regenerated nerve fiber diameter and myelin sheath thickness between the two groups. **p < 0.01, ****p < 0.0001, the NESC group vs the CTRL group.

Number of retrogradely labeled DRG neurons and sciatic nerves

To detect the reconstruction of neural pathways, we used a Lumafluor fluorescent tracer to detect the neural pathway in experimental animals 14 weeks after the operation. Lumafluor-labeled motor neurons showing green fluorescence could be detected in the anterior horn of the spinal cord in both groups of animals. The number of labeled-positive cells in the NESCs group was significantly greater than that in the control group (Fig. 5A,B). The number of labeled sciatic nerves in the NESCs group was obviously greater than that in the control group (Fig. 5C,D). These results were statistically significant (Fig. 5E). All these results indicated that the neural pathway was mainly reconstructed (Table 2).Fig. 5 The results of the Lumafluor fluorescent tracer. (A) Cells in the anterior horn of the spinal cord in the CTRL group. (B) Positive cells labeled with group NESCs in the anterior horn of the spinal cord. (C) Retrogradely labeled sciatic nerves in the CTRL group. (D) Retrograde-labeled sciatic nerves in the NESC group. (E) Comparison of fluorescent tracer-labeled positive cells between the two groups. *p < 0.05, ****p < 0.0001 for the comparison between the NESC group and the CTRL group.

Table 2 Comparisons of regenerated nerve fiber density, regenerated nerve fiber diameter and myelin sheath thickness between the two groups.

	Density of regenerated fibers (number/mm2)	Regenerated fiber diameter (μm)	Myelin area (μm2)	
Collagen-chitosan scaffolds group (Control group)	33.25 ± 13.4	4.648 ± 0.243	40.44 ± 1.25	
NESCs-collagen-chitosan scaffolds group (NESCs group)	48.62 ± 15.8	5.484 ± 0.312	52.24 ± 1.07	

Discussion

The objective of this study was to investigate the potential of delivering NESCs to a collagen protein-chitosan nerve conduit to promote peripheral nerve regeneration. Our data indicate that NESCs grafted to collagen-chitosan scaffolds can improve the regeneration and function of the sciatic nerve after a transected lesion in vivo. The results presented in this study have implications for future therapeutic applications using neuroepithelial stem cells delivered in a collagen protein-chitosan nerve conduit to enhance peripheral nerve repair.

Peripheral nerve injury is a common and frequently occurring disease in the clinic. The regeneration and repair of nerve injury is a hot research topic for scholars at home and abroad16. By means of nerve stump anastomosis, nerve transplantation, or bridging nerve stumps by implanting a nerve guiding catheter, a good microenvironment can be provided for nerve regeneration. Recently, it has been reported that chitosan-polyethoxylate nerve grafts combined with bone marrow monocytes have achieved good clinical results in repairing median nerve damage17. However, the transplant process has risks of complications such as rejection and infection. Biological graft materials with few rejection reactions, good biocompatibility and degradability can provide a good solution for peripheral nerve injury. Nerve conduits play a role in supporting and guiding nerve fiber regeneration in the repair of peripheral nerve injury, providing a good local regeneration microenvironment for nerve repair.

The collagen-chitosan composite catheter used in this study was prepared by combining collagen and chitosan at a 3:1 ratio. The composite scaffold provides a suitable microenvironment for nerve cell-surrounding interactions to facilitate tissue regeneration. The collagen-chitosan catheter was completely degraded at 14 weeks after surgery in vivo, and the surface of the material had good degradability and biocompatibility, providing a suitable time and space for the regeneration of nerve axons13. Different mass ratios of collagen/chitosan affect the degradation time and biocompatibility of the composites. A recent study demonstrated that a collagen/chitosan scaffold with a mass ratio of 1:8 was completely degraded 6 months after transplantation and was the most suitable material for traumatic brain injury repair5. As the collagen/chitosan ratio decreased, the degradation time of the composites gradually increased. The degradation rate of the desired scaffold should match the time required for tissue repair.

Our findings show that the collagen-chitosan composite is biocompatible with NESCs and that inoculated NESCs not only survive well but also grow protrusions. Studies on the repair of peripheral nerve injury have demonstrated that chitosan promotes peripheral nerve regeneration by supporting axonal regeneration and reducing scar tissue formation18,19. The combination of appropriate materials with chitosan can be used as a nerve guiding catheter for cell therapy for the treatment of peripheral nerve injury18,20. NESCs are neural stem cells with multidifferentiation potential that play important roles as seed cells in the repair of nervous system diseases and peripheral nerve damage21,22. In this study, after 5 days of culture, NESCs obtained from early neural tubes grew into neurospheres composed of dozens or even hundreds of cells, indicating that these cells have a very strong ability to proliferate. After 48 h, the adherent cells grew out of the protrusions and connected with each other, indicating that the NESCs had good compatibility with the collagen-chitosan scaffolds. Previous studies showed that NESCs can survive well on chitosan fibers and differentiate into neurons, astrocytes and a few Schwann-like cells expressing S-10013. Electrophysiological tests revealed that the motor conduction potential rate and amplitude of the regenerated nerves in the NESCs group were significantly better than those in the control group, indicating that the motor conduction function recovery of the regenerated nerve in the NESCs group was better than that in the simple collagen-chitosan conduit group.

This finding was confirmed by toluidine blue staining and TEM analysis. The results of toluidine blue staining and TEM analysis showed that the neural fiber regeneration and diameter of myelinated fibers in the NESCs group were greater than those in the control group. Retrograde tracing revealed labeled neurons in the anterior horn of the spinal cord in both groups of animals at 14 weeks after the operation, indicating that the proximal end of the defective nerve had reached the distal end through regeneration and that axonal transport was restored. The number of labeled neurons in the NESCs group was greater than that in the collagen-chitosan group. The number of labeled cells in sciatic nerves in the NESCs group was much greater than that in the collagen-chitosan conduit group. These findings prove that NESCs can more effectively promote the regeneration and repair of damaged nerves. All these results indicated that the neural pathway was mainly reconstructed and that NESCs exhibited superior nerve regeneration characteristics.

The mechanism by which the NESCs-collagen-chitosan scaffold promotes peripheral nerve regeneration is multifaceted and comprehensive. The growth and maturation of regenerated axons are largely limited by local microenvironmental factors during nerve regeneration, such as cells, the extracellular matrix, and various cytokines. Transplanted neural stem cells can locally proliferate and induce differentiation into specific cells to compensate for damaged neurons. Transplanted cells inhibit neurodegeneration or promote nerve regeneration by releasing neurotransmitters such as dopamine, acetylcholine, and various neurotrophic factors23,24. Studies have shown that neural stem cells can secrete GDNF, BDNF, nerve growth factor and other nutritional factors, which can be detected not only quantitatively in vitro, but also at a high level after being implanted in rats with spinal cord injury25. In addition, Llado et al. reported that NSCs can secrete NTFs to promote the survival of injured motor nerve cells and reduce the toxic damage to nerve cells by antagonizing excitatory glutamate26. However, the mechanism by which NESCs promote peripheral nerve regeneration is complex, and further research on the mechanism by which transplanted cells promote nerve regeneration is needed.

Conclusion

In conclusion, we used NESCs as seed cells combined with chitosan-collagen to construct tissue engineering bridges, providing a favorable regenerative microenvironment for peripheral nerves. In addition to the effects of NESCs, an unknown mechanism, for example, cytokine or inflammation, might be involved in enhancing nerve regeneration. This study demonstrated that it can promote peripheral nerve repair and has good application prospects and potential research value. In addition, through “therapeutic cloning”, that is, cloning early embryos and extracting stem cells through somatic cell nuclear transfer technology, autologous differentiated cells are generated for therapeutic purposes. Therefore, with the further development of science and technology in the future, the source of neural stem cells may be commercialized and widely used in clinical treatment.

Acknowledgements

This work was supported by the Shandong Provincial Medical and Health Science and Technology Development Plan (202104040051) and the Youth Science Fund Cultivation Grant Program of Shandong First Medical University (Shandong Academy of Medical Sciences) (No. 202201-106).

Author contributions

Y-CP and L-W: conception, analysis and writing of the manuscript; Q-BM, Q-YJ and X-HC: methodology, analysis and validation; X-T and L-T: discussed the final edition and was responsible for the overall content; all the authors have read and approved the final version of the manuscript.

Data availability

The data that support the findings of this study are available upon request from the corresponding author.

Competing interests

The authors declare no competing interests.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Chenping Yun and Wei Li.
==== Refs
References

1. Min Q Parkinson DB Dun XP Migrating Schwann cells direct axon regeneration within the peripheral nerve bridge Glia 2021 69 235 254 10.1002/glia.23892 32697392
Min, Q., Parkinson, D. B. & Dun, X. P. Migrating Schwann cells direct axon regeneration within the peripheral nerve bridge. Glia 69, 235–254 (2021).32697392 10.1002/glia.23892
2. Lavorato A Mesenchymal stem cell treatment perspectives in peripheral nerve regeneration: Systematic review Int. J. Mol. Sci. 2021 22 572 10.3390/ijms22020572 33430035
Lavorato, A. et al. Mesenchymal stem cell treatment perspectives in peripheral nerve regeneration: Systematic review. Int. J. Mol. Sci. 22, 572 (2021).33430035 10.3390/ijms22020572
3. Yao L DeBrot A Preparation of bioscaffolds delivering stem cells for neural regeneration Methods Mol. Biol. 2020 2155 63 70 10.1007/978-1-0716-0655-1_5 32474867
Yao, L. & DeBrot, A. Preparation of bioscaffolds delivering stem cells for neural regeneration. Methods Mol. Biol. 2155, 63–70 (2020).32474867 10.1007/978-1-0716-0655-1_5
4. Kaminska A Radoszkiewicz K Rybkowska P Wedzinska A Sarnowska A Interaction of neural stem cells (NSCs) and mesenchymal stem cells (MSCs) as a promising approach in brain study and nerve regeneration Cells 2022 11 1464 10.3390/cells11091464 35563770
Kaminska, A., Radoszkiewicz, K., Rybkowska, P., Wedzinska, A. & Sarnowska, A. Interaction of neural stem cells (NSCs) and mesenchymal stem cells (MSCs) as a promising approach in brain study and nerve regeneration. Cells 11, 1464 (2022).35563770 10.3390/cells11091464
5. Zheng D ROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis Front. Immunol. 2022 13 1039241 10.3389/fimmu.2022.1039241 36389728
Zheng, D. et al. ROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis. Front. Immunol. 13, 1039241 (2022).36389728 10.3389/fimmu.2022.1039241
6. Boecker A Daeschler SC Kneser U Harhaus L Relevance and recent developments of chitosan in peripheral nerve surgery Front. Cell Neurosci. 2019 13 104 10.3389/fncel.2019.00104 31019452
Boecker, A., Daeschler, S. C., Kneser, U. & Harhaus, L. Relevance and recent developments of chitosan in peripheral nerve surgery. Front. Cell Neurosci. 13, 104 (2019).31019452 10.3389/fncel.2019.00104
7. Sun Y 3D printing collagen/chitosan scaffold ameliorated axon regeneration and neurological recovery after spinal cord injury J. Biomed. Mater. Res. A 2019 107 1898 1908 10.1002/jbm.a.36675 30903675
Sun, Y. et al. 3D printing collagen/chitosan scaffold ameliorated axon regeneration and neurological recovery after spinal cord injury. J. Biomed. Mater. Res. A 107, 1898–1908 (2019).30903675 10.1002/jbm.a.36675
8. Guo S Enhanced effects of electrospun collagen-chitosan nanofiber membranes on guided bone regeneration J. Biomater. Sci. Polym. Ed. 2020 31 155 168 10.1080/09205063.2019.1680927 31710268
Guo, S. et al. Enhanced effects of electrospun collagen-chitosan nanofiber membranes on guided bone regeneration. J. Biomater. Sci. Polym. Ed. 31, 155–168 (2020).31710268 10.1080/09205063.2019.1680927
9. Shagdarova B Collagen/chitosan gels cross-linked with genipin for wound healing in mice with induced diabetes Materials 2021 15 15 10.3390/ma15010015 35009173
Shagdarova, B. et al. Collagen/chitosan gels cross-linked with genipin for wound healing in mice with induced diabetes. Materials 15, 15 (2021).35009173 10.3390/ma15010015
10. Liu X Integrated printed BDNF/collagen/chitosan scaffolds with low temperature extrusion 3D printer accelerated neural regeneration after spinal cord injury Regener. Biomater. 2021 8 047
Liu, X. et al. Integrated printed BDNF/collagen/chitosan scaffolds with low temperature extrusion 3D printer accelerated neural regeneration after spinal cord injury. Regener. Biomater. 8, 047 (2021).
11. Liu X Three-dimensional-printed collagen/chitosan/secretome derived from HUCMSCs scaffolds for efficient neural network reconstruction in canines with traumatic brain injury Regener. Biomater. 2022 9 043 10.1093/rb/rbac043
Liu, X. et al. Three-dimensional-printed collagen/chitosan/secretome derived from HUCMSCs scaffolds for efficient neural network reconstruction in canines with traumatic brain injury. Regener. Biomater. 9, 043 (2022).10.1093/rb/rbac043
12. Hammouda H Farag M El Deftar M Abdel-Gabbar M Mohamed B Effect of Ce-doped bioactive glass/collagen/chitosan nanocomposite scaffolds on the cell morphology and proliferation of rabbit’s bone marrow mesenchymal stem cells-derived osteogenic cells J. Genet. Eng. Biotechnol. 2022 20 33 10.1186/s43141-022-00302-x 35192077
Hammouda, H., Farag, M., El Deftar, M., Abdel-Gabbar, M. & Mohamed, B. Effect of Ce-doped bioactive glass/collagen/chitosan nanocomposite scaffolds on the cell morphology and proliferation of rabbit’s bone marrow mesenchymal stem cells-derived osteogenic cells. J. Genet. Eng. Biotechnol. 20, 33 (2022).35192077 10.1186/s43141-022-00302-x
13. Fang P Survival and differentiation of neuroepithelial stem cells on chitosan bicomponent fibers Chin. J. Physiol. 2010 53 208 214 10.4077/CJP.2010.AMK047 21793330
Fang, P. et al. Survival and differentiation of neuroepithelial stem cells on chitosan bicomponent fibers. Chin. J. Physiol. 53, 208–214 (2010).21793330 10.4077/CJP.2010.AMK047
14. Yan F Collagen-chitosan scaffold impregnated with bone marrow mesenchymal stem cells for treatment of traumatic brain injury Neural Regener. Res. 2019 14 1780 1786 10.4103/1673-5374.257533
Yan, F. et al. Collagen-chitosan scaffold impregnated with bone marrow mesenchymal stem cells for treatment of traumatic brain injury. Neural Regener. Res. 14, 1780–1786 (2019).10.4103/1673-5374.257533
15. Xiao W Rapid sciatic nerve regeneration of rats by a surface modified collagen-chitosan scaffold Injury 2013 44 941 946 10.1016/j.injury.2013.03.029 23642627
Xiao, W. et al. Rapid sciatic nerve regeneration of rats by a surface modified collagen-chitosan scaffold. Injury 44, 941–946 (2013).23642627 10.1016/j.injury.2013.03.029
16. Modrak M Talukder MAH Gurgenashvili K Noble M Elfar JC Peripheral nerve injury and myelination: Potential therapeutic strategies J. Neurosci. Res. 2020 98 780 795 10.1002/jnr.24538 31608497
Modrak, M., Talukder, M. A. H., Gurgenashvili, K., Noble, M. & Elfar, J. C. Peripheral nerve injury and myelination: Potential therapeutic strategies. J. Neurosci. Res. 98, 780–795 (2020).31608497 10.1002/jnr.24538
17. Gu X Combined use of chitosan-PGLA nerve grafts and bone marrow mononuclear cells to repair a 50-mm-long median nerve defect combined with an 80-mm-long ulnar nerve defect in the human upper arm Curr. Stem Cell Res. Ther. 2022 17 389 10.2174/1574888X17666220404195534 35379140
Gu, X. et al. Combined use of chitosan-PGLA nerve grafts and bone marrow mononuclear cells to repair a 50-mm-long median nerve defect combined with an 80-mm-long ulnar nerve defect in the human upper arm. Curr. Stem Cell Res. Ther. 17, 389 (2022).35379140 10.2174/1574888X17666220404195534
18. Poongodi R Bio-scaffolds as cell or exosome carriers for nerve injury repair Int. J. Mol. Sci. 2021 22 13347 10.3390/ijms222413347 34948144
Poongodi, R. et al. Bio-scaffolds as cell or exosome carriers for nerve injury repair. Int. J. Mol. Sci. 22, 13347 (2021).34948144 10.3390/ijms222413347
19. Zhang N Modulating cationicity of chitosan hydrogel to prevent hypertrophic scar formation during wound healing Int. J. Biol. Macromol. 2020 154 835 843 10.1016/j.ijbiomac.2020.03.161 32194120
Zhang, N. et al. Modulating cationicity of chitosan hydrogel to prevent hypertrophic scar formation during wound healing. Int. J. Biol. Macromol. 154, 835–843 (2020).32194120 10.1016/j.ijbiomac.2020.03.161
20. Pop NL Chitosan functionalized magnetic nanoparticles to provide neural regeneration and recovery after experimental model induced peripheral nerve injury Biomolecules 2021 11 376 10.3390/biom11050676 33801562
Pop, N. L. et al. Chitosan functionalized magnetic nanoparticles to provide neural regeneration and recovery after experimental model induced peripheral nerve injury. Biomolecules 11, 376 (2021).33801562 10.3390/biom11050676
21. Taverna E Huttner WB The golgi apparatus in polarized neuroepithelial stem cells and their progeny: Canonical and noncanonical features Results Probl. Cell Differ. 2019 67 359 375 10.1007/978-3-030-23173-6_15 31435803
Taverna, E. & Huttner, W. B. The golgi apparatus in polarized neuroepithelial stem cells and their progeny: Canonical and noncanonical features. Results Probl. Cell Differ. 67, 359–375 (2019).31435803 10.1007/978-3-030-23173-6_15
22. Binh NT Proliferation and differentiation of dopaminergic neurons from human neuroepithelial stem cells obtained from embryo reduction following in vitro fertilization Med. Arch. 2021 75 280 285 10.5455/medarh.2021.75.280-285 34759448
Binh, N. T. et al. Proliferation and differentiation of dopaminergic neurons from human neuroepithelial stem cells obtained from embryo reduction following in vitro fertilization. Med. Arch. 75, 280–285 (2021).34759448 10.5455/medarh.2021.75.280-285
23. Anderson K Behavioral context improves optogenetic stimulation of transplanted dopaminergic cells in unilateral 6-OHDA rats Behav. Brain Res. 2023 441 114279 10.1016/j.bbr.2022.114279 36586489
Anderson, K. et al. Behavioral context improves optogenetic stimulation of transplanted dopaminergic cells in unilateral 6-OHDA rats. Behav. Brain Res. 441, 114279 (2023).36586489 10.1016/j.bbr.2022.114279
24. Gori S Acetylcholine-treated murine dendritic cells promote inflammatory lung injury PLoS ONE 2019 14 e0212911 10.1371/journal.pone.0212911 30822345
Gori, S. et al. Acetylcholine-treated murine dendritic cells promote inflammatory lung injury. PLoS ONE 14, e0212911 (2019).30822345 10.1371/journal.pone.0212911
25. Lu P Jones LL Snyder EY Tuszynski MH Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury Exp. Neurol. 2003 181 115 129 10.1016/S0014-4886(03)00037-2 12781986
Lu, P., Jones, L. L., Snyder, E. Y. & Tuszynski, M. H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol. 181, 115–129 (2003).12781986 10.1016/S0014-4886(03)00037-2
26. Lladó J Haenggeli C Maragakis NJ Snyder EY Rothstein JD Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors Mol. Cell. Neurosci. 2004 27 322 331 10.1016/j.mcn.2004.07.010 15519246
Lladó, J., Haenggeli, C., Maragakis, N. J., Snyder, E. Y. & Rothstein, J. D. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol. Cell. Neurosci. 27, 322–331 (2004).15519246 10.1016/j.mcn.2004.07.010
